๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Metastatic Melanoma

Naltrexone and Propranolol Combined With Immunotherapy NCT05968690Phase 11 site๐Ÿ“ New Brunswick Sarah Weiss ยท Tests: Propranolol, Naltrexone Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391Phase 12 sites๐Ÿ“ Sydney๐Ÿ“ Melbourne St Vincent's Hospital, Sydney ยท Tests: roginolisib A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab NCT02621021Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: young TIL, Pembrolizumab, Aldesleukin, Fludarabine, Cyclophosphamide A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Tebentafusp-tebn With LDT in Metastatic UM NCT06626516Phase 1, Phase 21 site๐Ÿ“ Philadelphia Thomas Jefferson University ยท Tests: Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade NCT07130032Phase 21 site๐Ÿ“ Saint Petersburg EuroCityClinic LLC ยท Tests: reICB regimen (NSCLC), reICB regimen (melanoma) Versatile Ampification Single-Molecule Detection in Liquid Biopsy NCT05940311n/a1 site๐Ÿ“ Rome Regina Elena Cancer Institute ยท Tests: Blood sampling in addition to the blood normally required for their clinical management, Blood plasma and circulating tโ€ฆ Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Denver๐Ÿ“ Nashville Novelwise Pharmaceutical Corporation ยท Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment ofโ€ฆ A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma NCT07057596Phase 24 sites๐Ÿ“ Berlin๐Ÿ“ L'Hospitalet de Llobregat๐Ÿ“ Madrid Grupo Espaรฑol Multidisciplinar de Melanoma ยท Tests: Tebentafusp Mirdametinib in Patients With Advanced NF1-mutant Melanoma NCT07237100Phase 21 site๐Ÿ“ San Francisco Kevin Kim, MD ยท Tests: Mirdametinib Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma NCT04598009Phase 22 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Binimetinib, Imatinib Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site๐Ÿ“ Columbus Carlo Contreras ยท Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317Phase 22 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivoยฎ as Adjuvant Monotherapy in Participants With Melanoma NCT07476326Phase 146 sites๐Ÿ“ Bento Gonรงalves๐Ÿ“ Ijuรญ๐Ÿ“ Parรก Biocon Biologics UK PLC ยท Tests: Bmab1700, Opdivo Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma NCT07276386Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Melphalan/HDS (Percutaneous Hepatic Perfusion), Tebentafusp Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis NCT07281924Phase 1, Phase 21 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: Nivolumab and Relatlimab, Melphalan EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Rancho Santa Margarita๐Ÿ“ Weston Krystal Biotech, Inc. ยท Tests: KB707, Opdualag, KEYTRUDA ยฎ( Pembrolizumab) Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers NCT07415564NA1 site๐Ÿ“ Tucson University of Arizona ยท Tests: Symptom Management and Survivorship Handbook + Coaching, Symptom Management and Survivorship Handbook Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma NCT07631325Phase 1, Phase 21 site๐Ÿ“ Pittsburgh John Kirkwood ยท Tests: Axelopran, Nivolumab Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites๐Ÿ“ Berlin๐Ÿ“ Cologne๐Ÿ“ Erlangen Miltenyi Biomedicine GmbH ยท Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma NCT06295159Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Nivolumab, Nivolumab + Relatlimab, Ipilimumab GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites๐Ÿ“ Goyang-si๐Ÿ“ Seoul๐Ÿ“ Seoul GeneMedicine Co., Ltd. ยท Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer NCT05522660Phase 315 sites๐Ÿ“ Naples๐Ÿ“ Padova๐Ÿ“ Perugia ETOP IBCSG Partners Foundation ยท Tests: Stereotactic radiosurgery, Immune checkpoint inhibitor AMT-253 in Patients With Advanced Solid Tumours NCT06209580Phase 1, Phase 21 site๐Ÿ“ Beijing Multitude Therapeutics Inc. ยท Tests: AMT-253 for injection Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab Dabrafenib and/or Trametinib Rollover Study NCT03340506Phase 438 sites๐Ÿ“ Scottsdale๐Ÿ“ Bethesda๐Ÿ“ Columbus Novartis Pharmaceuticals ยท Tests: dabrafenib, trametinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy